TotalMarketCap

Aardvark Therapeutics

AARDNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$24.511 M

$1.12 -11.11%

Close of 6 Nov 2026

As of 6 Nov 2026, Aardvark Therapeutics (AARD) has a market capitalization of $24.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$57.6M

Loss-making

Shares outstanding

21,884,846

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #370Abvc BiopharmaABVC$26.3M
  2. #371Transcode TherapeuticsRNAZ$25.4M
  3. #372Aardvark TherapeuticsAARD$24.5M
  4. #373Shuttle PharmaceuticalsSHPH$24.3M
  5. #374CelularityCELU$23.7M

What if Aardvark Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,290,248

Per share 1,152,007× higher

Bitcoin $1.53T

$69,813.06

Per share 62,333× higher

Apple $5.02T

$229,189.76

Per share 204,634× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Aardvark Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.